Hims & Hers faces backlash over ‘misleading' Super Bowl ad—but it didn't stop stock from jumping over 11%Fast Company • 02/09/25
Global Healthy Living Foundation Says Hims & Hers Health Super Bowl Ad Omits Risks of Weight Loss DrugBusiness Wire • 02/08/25
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today24/7 Wall Street • 02/07/25
Hims & Hers Health, Inc. (HIMS) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 02/05/25
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025Business Wire • 02/03/25
Hims & Hers Health, Inc. (HIMS) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 01/29/25
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped TodayThe Motley Fool • 01/17/25
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdownCNBC • 12/24/24
4 MedTech Stocks That Gained More Than 100% in 2024 With Room to RunZacks Investment Research • 12/23/24